Abstract
This chapter introduces “Individualized Medicine” as a technical term. In order to do this the chapter first gives a precise, logical and conceptual analysis of relevant explanations and definitions from English and German speaking areas. It secondly presents a definition according to which the term “Individualized Medicine” should be used for describing research approaches and health care practices, when the biomarker-based prediction of (a) diseases and/or (b) the effectiveness of therapies by stratification is central. The relevant terms “research approach”, “health care practice”, “biomarker”, “prediction” and “stratification” will be discussed in detail. Finally the term “Individualized Medicine” will be examined regarding its extension and be compared to “Personalized Medicine”, which is also understood terminologically.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ameling S, Herda LR, Hammer E et al (2013) Myocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapy. Eur Heart J 34(9):666–675
Costigliola V, Gahan P, Golubnitschaja O (2009) Predictive medicine as the new philosophy in healthcare. Introduction of the general concept. In: Golubnitschaja O (ed) Predicitive diagnostics and personalized treatment. Nova Publishers, New York, p 1–3
Felix SB, Staudt A (2008) Immunoadsorption as treatment option in dilated cardiomyopathy. Autoimmunity 41(6):484–489
Fricke A (2011) Individualisierte Medizin: Hoffnung und Risiko zugleich. Deutsche Ärzte Zeitung 22.02.2011. http://www.aerztezeitung.de/politik_gesellschaft/arzneimittelpolitik/article/642186/individualisierte-medizin-hoffnung-risiko-zugleich.html. Accessed 27 June 2014
Grabe HJ, Assel H, Bahls T et al (2014) Cohort profile: Greifswald approach to individualized medicine (GANI_MED). J Transl Med 12:144
Hasler-Strub U (2009) Aktuelle Therapien beim metastasierten Brustkrebs. Eine Übersicht über evidenzbasierte Optionen. Schweizer Zeitschrift für Onkologie 5:20–22
Herda LR, Trimpert C, Nauke U et al (2010) Effects of immunoadsorption and subsequent immunoglobulin G substitution on cardiopulmonary exercise capacity in patients with dilated cardiomyopathy. Am Heart J 159(5):809–816
Hüsing B, Hartig J, Bührlen B et al (2008) Individualisierte Medizin und Gesundheitssystem, TAB-Arbeitsbericht Nr. 126. http://www.tab-beim-bundestag.de/de/publikationen/berichte/ab126.html. Accessed 27 June 2014
Individualisierte Medizin: Etikettenschwindel (2011). http://www.bdi.de/allgemeine-infos/aktuelle-meldungen/ansicht/article/individualisierte-medizin-etikettenschwindel.html. Accessed 27 June 2014
Kollek R, Lemke T (2008) Der medizinische Blick in die Zukunft. Gesellschaftliche Implikationen prädiktiver Gentests. Campus-Verlag, Frankfurt a. M.
Kuhn TS (1970) The structure of scientific revolutions, 2 edn. University of Chicago Press, Chicago
Lakatos I (1978) The methodology of scientific research programmes, philosophical papers Vol. 1. Cambridge University Press, Cambridge
Langanke M, Brothers KB, Erdmann P et al (2011) Comparing different scientific approaches to personalized medicine: research ethics and privacy protection. Per Med 8(4):437–444
Langanke M, Erdmann P, Dörr M et al (2012a) Gesundheitsökonomische Forschung im Kontext Individualisierter Medizin: Forschungsethische und datenschutzrechtliche Aspekte am Beispiel des GANI_MED-Projekts. Pharmacoecon Ger Res Artic 10(2):105–121
Langanke M, Lieb W, Erdmann P et al (2012b) Was ist Individualisierte Medizin? Zur terminologischen Justierung eines schillernden Begriffs. Zeitschrift für medizinische Ethik 58:295–314
Manzeschke A (2011) Technische Assistenzsysteme. Eine Antwort auf die Herausforderung des demographischen Wandels? Pro Alter 5:36–40
Manzeschke A, Oehmichen F (2010) Tilgung des Zufälligen. Ethische Aspekte der Verantwortung in Ambient-Assisted-Living-Kontexten. Jahrbuch für Wissenschaft und Ethik 15:121–138
Marckmann G (2011) BMBF-Verbundprojekt „Individualisierte Gesundheitsversorgung: Ethische, ökonomische und rechtliche Implikationen für das deutsche Gesundheitswesen“. 1. Expertenworkshop, München, 20. September 2011. http://www.igv-ethik.de/vortraege/projektvorstellung.pdf. Accessed 27 June 2014
Niederlag W, Lemke HU, Golubnitschaja O et al (eds) (2010) Personalisierte Medizin. General Hospital, Dresden
Pfaff H (2006) Präventive Versorgung. Begriffsbestimmung und theoretisches Konzept. Prävention und Gesundheitsförderung 1:17–23
Presidentʼs Council of Advisors on Science and Technology (2008) Priorities for personalized medicine. Report of Presidentʼs Council of Advisors on Science and Technology, September 2008. http://www.whitehouse.gov/files/documents/ostp/PCAST/pcast_report_v2.pdf. Accessed 27 June 2014
Schleidgen S, Klingler C, Bertram T et al (2013) What is personalized medicine: sharpening a vague term based on a systematic literature review. BMC Medical Ethics 14:55
Staudt A, Herda LR, Trimpert C et al (2010) Fcgamma-receptor IIa polymorphism and the role of immunoadsorption in cardiac dysfunction in patients with dilated cardiomyopathy. Clin Pharmacol Ther 87(4):452–458
Staudt A, Eichler P, Trimpert C et al (2007) Fc(gamma) receptors IIa on cardiomyocytes and their potential functional relevance in dilated cardiomyopathy. J Am Coll Cardiol 49(16):1684–1692
Staudt A, Hummel A, Ruppert J et al (2006) Immunoadsorption in dilated cardiomyopathy: 6-month results from a randomized study. Am Heart J 152(4):712.e711–712.e716
Trimpert C, Herda LR, Eckerle LG et al (2010) Immunoadsorption in dilated cardiomyopathy: long-term reduction of cardiodepressant antibodies. Eur J Clin Invest 40(8):685–691
Vasan RS (2006) Biomarkers of cardiovascular disease. Molecular basis and practical considerations. Circulation 113:2335–2362
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Langanke, M. et al. (2015). The Meaning of “Individualized Medicine”: A Terminological Adjustment of a Perplexing Term. In: Fischer, T., Langanke, M., Marschall, P., Michl, S. (eds) Individualized Medicine. Advances in Predictive, Preventive and Personalised Medicine, vol 7. Springer, Cham. https://doi.org/10.1007/978-3-319-11719-5_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-11719-5_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-11718-8
Online ISBN: 978-3-319-11719-5
eBook Packages: MedicineMedicine (R0)